α1-antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice

Respiratory Research

Hong Wei Chu¹  Ashley Gross³  Qun Wu³  Rebecca Persinger²  Di Jiang³ 

[1] Department of Medicine, Room A639, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA;Grifols, Inc., Research Triangle Park, Durham, NC, USA;Department of Medicine, National Jewish Health, Denver, CO, USA

关键词: Human neutrophil elastase;    Pseudomonas aeruginosa infection;    α1-antitrypsin;    SPLUNC1;   

Others  :  792380
DOI  :  10.1186/1465-9921-14-122

 received in 2013-08-17, accepted in 2013-10-31,  发布年份 2013

【 摘 要 】

Background

Pseudomonas aeruginosa (PA) infection is involved in various lung diseases such as cystic fibrosis and chronic obstructive pulmonary disease. However, treatment of PA infection is not very effective in part due to antibiotic resistance. α1-antitrypsin (A1AT) has been shown to reduce PA infection in humans and animals, but the underlying mechanisms remain unclear. The goal of our study is to test whether a novel endogenous host defense protein, short palate, lung, and nasal epithelium clone 1 (SPLUNC1), is involved in the therapeutic effect of A1AT during lung PA infection.

Method

SPLUNC1 knockout (KO) and littermate wild-type (WT) mice on the C57BL/6 background were intranasally infected with PA to determine the therapeutic effects of A1AT. A1AT was aerosolized to mice 2 hrs after the PA infection, and mice were sacrificed 24 hrs later. PA load and inflammation were quantified in the lung, and SPLUNC1 protein in bronchoalveolar lavage (BAL) fluid was examined by Western blot.

Results

In WT mice, PA infection significantly increased neutrophil elastase (NE) activity, but reduced SPLUNC1 protein in BAL fluid. Notably, PA-infected mice treated with A1AT versus bovine serum albumin (BSA) demonstrated higher levels of SPLUNC1 protein expression, which are accompanied by lower levels of NE activity, lung bacterial load, and pro-inflammatory cytokine production. To determine whether A1AT therapeutic effects are dependent on SPLUNC1, lung PA load in A1AT- or BSA-treated SPLUNC1 KO mice was examined. Unlike the WT mice, A1AT treatment in SPLUNC1 KO mice had no significant impact on lung PA load and pro-inflammatory cytokine production.

Conclusion

A1AT reduces lung bacterial infection in mice in part by preventing NE-mediated SPLUNC1 degradation.

【 授权许可】

   
2013 Jiang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL: Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008, 47:1526-1533.
• [2]Valderrey AD, Pozuelo MJ, Jimenez PA, Macia MD, Oliver A, Rotger R: Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Diagn Microbiol Infect Dis 2010, 68:20-27.
• [3]Holm JP, Hilberg O, Noerskov-Lauritsen N, Bendstrup E: Pseudomonas aeruginosa in patients without cystic fibrosis is strongly associated with chronic obstructive lung disease. Dan Med J 2013, 60:A4636.
• [4]Carmeli Y, Troillet N, Eliopoulos GM, Samore MH: Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999, 43:1379-1382.
• [5]Griese M, Latzin P, Kappler M, Weckerle K, Heinzlmaier T, Bernhardt T, Hartl D: alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2007, 29:240-250.
• [6]Cantin AM, Woods DE: Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 1999, 160:1130-1135.
• [7]Jiang D, Wenzel SE, Wu Q, Bowler RP, Schnell C, Chu HW: Human Neutrophil Elastase Degrades SPLUNC1 and Impairs Airway Epithelial Defense against Bacteria. PLoS One 2013, 8:e64689.
• [8]Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, Leikauf GD, Kolls JK, Di YP: Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol 2011, 187:382-390.
• [9]Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, et al.: Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J Immunol 2007, 179:3995-4002.
• [10]Ekeowa UI, Marciniak SJ, Lomas DA: alpha(1)-antitrypsin deficiency and inflammation. Expert Rev Clin Immunol 2011, 7:243-252.
• [11]Silverman EK, Sandhaus RA: Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009, 360:2749-2757.
• [12]Fregonese L, Stolk J: Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis 2008, 3:16. BioMed Central Full Text
• [13]Wewers MD, Crystal RG: Alpha-1 antitrypsin augmentation therapy. COPD 2013, 10(Suppl 1):64-67.
• [14]Gally F, Di YP, Smith SK, Minor MN, Liu Y, Bratton DL, Frasch SC, Michels NM, Case SR, Chu HW: SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am J Pathol 2011, 178:2159-2167.
• [15]Bergsson G, Reeves EP, McNally P, Chotirmall SH, Greene CM, Greally P, Murphy P, O'Neill SJ, McElvaney NG: LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol 2009, 183:543-551.
• [16]Doring G: The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994, 150:S114-S117.
• [17]Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, Campos MA, Bingle CD: Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Respir Res 2007, 8:79. BioMed Central Full Text
• [18]Kuang Z, Hao Y, Walling BE, Jeffries JL, Ohman DE, Lau GW: Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One 2011, 6:e27091.
• [19]Chu HW, Gally F, Thaikoottathil J, Janssen-Heininger YM, Wu Q, Zhang G, Reisdorph N, Case S, Minor M, Smith S, et al.: SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling. Respir Res 2010, 11:155. BioMed Central Full Text
• [20]Churg A, Wang RD, Xie C, Wright JL: alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003, 168:199-207.
• [21]Lockett AD, Kimani S, Ddungu G, Wrenger S, Tuder RM, Janciauskiene SM, Petrache I: Alpha-1 Antitrypsin Modulates Lung Endothelial Cell Inflammatory Responses to TNFalpha. Am J Respir Cell Mol Biol 2013, 49(1):143-150.